Context Few data document current cardiovascular (CV) event rates in stable patients with atherothrombosis in a community setting. Differential event rates for patients with documented coronary artery disease (CAD), cerebrovascular disease (CVD), or peripheral arterial disease (PAD) or those at risk of these diseases have not been previously evaluated in a single international cohort. Objective To establish contemporary, international, 1-year CV event rates in outpatients with established arterial disease or with multiple risk factors for atherothrombosis. Design, Setting, and Participants The Reduction of Atherothrombosis for Continued Health (REACH) Registry is an international, prospective cohort of 68 236 patients with either establishe...
Aims: This study aimed to estimate the rate of cardiovascular (CV) events in the real world in patie...
BackgroundThe risk for subsequent major cardiovascular (CV) events among patients with very high-ris...
OBJECTIVE: Datasets regarding patients with abdominal aortic aneurysm (AAA) have almost universally ...
To determine 3-year event rates in outpatients with vascular disease enrolled in the REduction of At...
Objective: To report on 1-year cardiovascular (CV) event rates in patients with established cardiova...
Objective: To report on 1-year cardiovascular (CV) event rates in patients with established cardiova...
Background: Atherothrombotic diseases including cerebrovascular disease (CVD), coronary artery disea...
Atherothrombotic diseases including cerebrovascular disease (CVD), coronary artery disease (CAD), an...
SummaryIntroductionAtherothrombosis is a systemic, diffuse disease associated with a high risk of ca...
Context Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the g...
BACKGROUND: Atherothrombotic diseases including cerebrovascular disease (CVD), coronary artery disea...
Aims: This study aimed to estimate the rate of cardiovascular (CV) events in the real world in patie...
AimsTo determine 3-year event rates in outpatients with vascular disease enrolled in the REduction o...
AimsTo determine 3-year event rates in outpatients with vascular disease enrolled in the REduction o...
Cardiovascular event rates have been shown to increase substantially with the number of symptomatic ...
Aims: This study aimed to estimate the rate of cardiovascular (CV) events in the real world in patie...
BackgroundThe risk for subsequent major cardiovascular (CV) events among patients with very high-ris...
OBJECTIVE: Datasets regarding patients with abdominal aortic aneurysm (AAA) have almost universally ...
To determine 3-year event rates in outpatients with vascular disease enrolled in the REduction of At...
Objective: To report on 1-year cardiovascular (CV) event rates in patients with established cardiova...
Objective: To report on 1-year cardiovascular (CV) event rates in patients with established cardiova...
Background: Atherothrombotic diseases including cerebrovascular disease (CVD), coronary artery disea...
Atherothrombotic diseases including cerebrovascular disease (CVD), coronary artery disease (CAD), an...
SummaryIntroductionAtherothrombosis is a systemic, diffuse disease associated with a high risk of ca...
Context Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the g...
BACKGROUND: Atherothrombotic diseases including cerebrovascular disease (CVD), coronary artery disea...
Aims: This study aimed to estimate the rate of cardiovascular (CV) events in the real world in patie...
AimsTo determine 3-year event rates in outpatients with vascular disease enrolled in the REduction o...
AimsTo determine 3-year event rates in outpatients with vascular disease enrolled in the REduction o...
Cardiovascular event rates have been shown to increase substantially with the number of symptomatic ...
Aims: This study aimed to estimate the rate of cardiovascular (CV) events in the real world in patie...
BackgroundThe risk for subsequent major cardiovascular (CV) events among patients with very high-ris...
OBJECTIVE: Datasets regarding patients with abdominal aortic aneurysm (AAA) have almost universally ...